A detailed history of Quest Partners LLC transactions in Incyte Corp stock. As of the latest transaction made, Quest Partners LLC holds 6,019 shares of INCY stock, worth $446,188. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,019
Previous 2,284 163.53%
Holding current value
$446,188
Previous $151 Million 175.37%
% of portfolio
0.06%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$65.08 - $83.38 $243,073 - $311,424
3,735 Added 163.53%
6,019 $416 Million
Q3 2024

Nov 07, 2024

SELL
$57.33 - $68.61 $266,297 - $318,693
-4,645 Reduced 67.04%
2,284 $151 Million
Q2 2024

Aug 06, 2024

SELL
$51.18 - $63.75 $777,884 - $968,936
-15,199 Reduced 68.69%
6,929 $420 Million
Q1 2024

May 09, 2024

BUY
$56.55 - $66.59 $743,123 - $875,059
13,141 Added 146.22%
22,128 $1.26 Billion
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $468,761 - $576,875
8,987 New
8,987 $564 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.